Sonic Healthcare Ltd
ASX:SHL

Watchlist Manager
Sonic Healthcare Ltd Logo
Sonic Healthcare Ltd
ASX:SHL
Watchlist
Price: 27.01 AUD -0.81% Market Closed
Market Cap: 13B AUD
Have any thoughts about
Sonic Healthcare Ltd?
Write Note

Sonic Healthcare Ltd
PP&E Gross

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Sonic Healthcare Ltd
PP&E Gross Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company PP&E Gross CAGR 3Y CAGR 5Y CAGR 10Y
Sonic Healthcare Ltd
ASX:SHL
PP&E Gross
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Healthia Ltd
ASX:HLA
PP&E Gross
AU$85m
CAGR 3-Years
39%
CAGR 5-Years
78%
CAGR 10-Years
N/A
Integral Diagnostics Ltd
ASX:IDX
PP&E Gross
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Capitol Health Ltd
ASX:CAJ
PP&E Gross
AU$115m
CAGR 3-Years
5%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Australian Clinical Labs Ltd
ASX:ACL
PP&E Gross
AU$281.7m
CAGR 3-Years
6%
CAGR 5-Years
46%
CAGR 10-Years
N/A
H
Healius Ltd
ASX:HLS
PP&E Gross
AU$1.2B
CAGR 3-Years
-1%
CAGR 5-Years
30%
CAGR 10-Years
N/A
No Stocks Found

Sonic Healthcare Ltd
Glance View

Market Cap
13B AUD
Industry
Health Care
Economic Moat
None

Sonic Healthcare Ltd. began its journey in 1987, carved from a niche of independent pathology practices in Australia. It swiftly evolved into a global player, embracing a model that combines local expertise with the strength of an international network. The heart of Sonic's operations lies in its robust diagnostic services. Its laboratories process millions of tests each year, ensuring timely and accurate results across a spectrum of medical diagnostics, including pathology, radiology, and general practice medicine. This core service is augmented by state-of-the-art technology and a commitment to quality care, which has earned Sonic a reputation for reliability and excellence in the healthcare sector. Financially, Sonic Healthcare thrives on a business model that capitalizes on high volume and steady demand for medical diagnostic services. The company generates revenue through contracts with hospitals, clinics, and governments, providing essential health services that are non-discretionary and resilient, even in economic downturns. Growth is driven by strategic acquisitions and partnerships, which expand its footprint across regions like North America and Europe, ensuring a stream of diversified income. As healthcare spending continues to rise globally, Sonic Healthcare's business model remains well-positioned to leverage its international presence and expertise in diagnostic excellence, fueling sustainable growth and shareholder value over the long term.

SHL Intrinsic Value
32.37 AUD
Undervaluation 17%
Intrinsic Value
Price

See Also

Back to Top